Pharmacy directors hold clout over formularies
A new report urges sales reps to focus on pharmacy directors, P&T members, and chief medical officers when pitching new products.
To get drug products on hospital formularies, contacting CEOs and COOs at integrated delivery networks isn't the best way to go. Rather drug manufacturers' sales reps should focus on chief medical officers, pharmacy directors, and members of pharmacy and therapeutics committees. That's the recommendation of a new report, entitled "Sales Force Effectiveness: Benchmarking the Resources and Structure Required to Service the U.S. Hospital Marketplace," just issued by the market research consulting firm, Best Practices, LLC. The report advises that chief medical officers, pharmacy directors, and P&T members are more influential than network-level administrators when it comes to placing drugs on formularies.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
